Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion—A Phase 2, Prospective Interventional Study

Ron Ram*, Odelia Amit, Chava Perry, Yair Herishanu, Irit Avivi, Nadav Sarid, Arie Apel, Meir Preis, Ariel Aviv, Shirly Shapira, Tamir Shragai, Erel Joffe, Liat Shargian, Kathrin Herzog-Tsarfati, Nili Eylati, Luisa Acria, Gil Fridberg, Ronit Gold, Chen Glait-Santar, Sigi KayKinneret Gal-Rabinovich, Dina Rosenberg, Noga Setter-Marco, Ofrat Beyar-Katz

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion—A Phase 2, Prospective Interventional Study'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology